Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs). Issue 1 (16th February 2017)

• Record Type: Journal Article
• Authors: Cabibbo, G.; Cacciola, I.; Cannavò, M.R.; Madonia, S.; Calvaruso, V.; Petta, S.; Distefano, M.; Larocca, L.; Prestileo, T.; Tinè, F.; Digiacomo, A.; Bertino, G.; Giannitrapani, L.; Benanti, F.; Davì, A.; Volpes, R.; Scalisi, I.; Iacobello, C.; Mazzola, G.; Cartabellotta, F.; Guarneri, L.; Portelli, V.; Averna, A.; Russello, M.; Scifo, G.; Squadrito, G.; Raimondo, G.; Craxì, A.; Di Marco, V.; Cammà, C.
• Is Part Of: Digestive and liver disease. Volume 49:Issue 1(2017)Supplement
• Page Start: e59
• Publication Date: 2017-02-16
• Subjects: Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; 616.33005
• DOI: 10.1016/j.dld.2017.01.119
• Languages: English
• ISSNs: 1590-8658